Skip to main content English


Julia Raitanen
Julia Raitanen, MSc

Department of Biomedical Imaging and Image-guided Therapy (Division of Nuclear Medicine)
Position: PHD Student

ORCID: 0000-0002-8115-3062
T +43 1 40400 78300


Drug Evaluation, Preclinical; Oncology; Radiobiology; Radiochemistry; Radiopharmaceuticals

Research interests

My main research interest lies in (targeted) radiotherapy of cancer, including novel approaches of Auger Electron Therapy. In this context, I currently focus on therapeutic efficacy studies in 2D and 3D cell culture systems.

Selected publications

  1. Raitanen, J. et al. (2023) ‘Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines’, Cells, 12(3), p. 360. Available at:
  2. Balber, T. et al. (2022) ‘Experimental Nuclear Medicine Meets Tumor Biology’, Pharmaceuticals, 15(2), p. 227. Available at:
  3. Bamminger, K. et al. (2022) ‘Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application’, Nuclear Medicine and Biology, 114–115, pp. 189–197. Available at:
  4. Godbersen, G.M. et al. (2023) ‘Task-evoked metabolic demands of the posteromedial default mode network are shaped by dorsal attention and frontoparietal control networks’, eLife, 12. Available at: